Author details

Full Name

P Robert Beatty

Affiliation

School of Public Health, University of California berkeley

ORCID

Career Start Year

1990

Papers

H Index

Expertise

CM4AI Collaborator

Nevan J Krogan (CM4AI)

PMID	Paper Title	Journal Title	Published Year
37425955	Yellow fever disease severity and endothelial dysfunction are associated with elevated serum levels of viral NS1 protein and syndecan-1.	medRxiv	2023
36494335	SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-Î² signaling.	Nat Commun	2022
35730550	Workshop-based learning and networking: a scalable model for research capacity strengthening in low- and middle-income countries.	Glob Health Action	2022
35533778	Sulfated Î²-glucan from Agaricus subrufescens inhibits flavivirus infection and nonstructural protein 1-mediated pathogenesis.	Antiviral Res	2022
35745469	Flavivirus NS1 Triggers Tissue-Specific Disassembly of Intercellular Junctions Leading to Barrier Dysfunction and Vascular Leak in a GSK-3Î²-Dependent Manner.	Pathogens	2022
33414220	Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction.	Science	2021
34931188	SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-Î² signaling.	bioRxiv	2021
30642979	Cyclic Dinucleotide-Adjuvanted Dengue Virus Nonstructural Protein 1 Induces Protective Antibody and T Cell Responses.	J Immunol	2019
31526452	Increased serum sialic acid is associated with morbidity and mortality in a murine model of dengue disease.	J Gen Virol	2019
30726741	Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism.	Cell Rep	2019
30044715	The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis.	Annu Rev Virol	2018
29121099	Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components.	PLoS Pathog	2017
28381638	Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.	J Immunol	2017
26946111	Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4.	Antiviral Res	2016
26974655	Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.	PLoS Negl Trop Dis	2016
26973790	Focal therapy using magnetic resonanceÂ image-guided focused ultrasound in patients with localized prostate cancer.	J Ther Ultrasound	2016
25938762	A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice.	PLoS One	2015
26355030	Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination.	Sci Transl Med	2015
24316047	Innate immunity to dengue virus infection and subversion of antiviral responses.	J Mol Biol	2014
25046459	Recurrent basal cell carcinoma with intracranial invasion: a case report and literature review.	Dermatol Online J	2014
22131327	Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.	J Immunol	2012
23070155	Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo.	Antimicrob Agents Chemother	2012
22815273	Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor.	J Gen Virol	2012
20368988	On-chip magnetic separation of superparamagnetic beads for integrated molecular analysis.	J Appl Phys	2010
20168989	Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification.	PLoS Pathog	2010
19270292	Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining.	Am J Trop Med Hyg	2009
19751398	A mouse model for studying dengue virus pathogenesis and immune response.	Ann N Y Acad Sci	2009
18774583	Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model.	Virology	2008
17518946	Atypical cutaneous leishmaniasis cases display elevated antigen-induced interleukin-10.	Parasite Immunol	2007
17492597	Dengue virus infects macrophages and dendritic cells in a mouse model of infection.	J Infect Dis	2007
16842813	A novel magnetic bead bioassay platform using a microchip-based sensor for infectious disease diagnosis.	J Immunol Methods	2006
17005698	Murine model for dengue virus-induced lethal disease with increased vascular permeability.	J Virol	2006
16148142	Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice.	J Immunol	2005
14990690	Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical.	J Virol	2004
9603174	CD30 expression identifies a functional alloreactive human T-lymphocyte subset.	Transplantation	1998
9521208	Human hepatocytes produce an isoform of FAS that inhibits apoptosis.	Transplantation	1998
9603175	Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines.	Transplantation	1998
9038302	Cross-reactive cytotoxic T-lymphocyte-mediated lysis of Chlamydia trachomatis- and Chlamydia psittaci-infected cells.	Infect Immun	1997
9126962	Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines.	J Immunol	1997
8675291	Cytotoxic-T-lymphocyte-mediated cytolysis of L cells persistently infected with Chlamydia spp.	Infect Immun	1996
7963531	CD8+ T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway.	J Immunol	1994
1398973	Identification of Chlamydia trachomatis antigens by use of murine T-cell lines.	Infect Immun	1992
1500180	Immune specificity of murine T-cell lines to the major outer membrane protein of Chlamydia trachomatis.	Infect Immun	1992
2287277	Cysteine-rich outer membrane proteins of Chlamydia trachomatis display compensatory sequence changes between biovariants.	Mol Microbiol	1990

1 - 44 of 44

Peiwen Lu

Yale University School of Medicine

Career Start Year 2013

Number of shared co-authors 0

Craig B Wilen

Yale School of Medicine

Career Start Year 2010

Number of shared co-authors 5

Sunil Thomas

Lankenau Institute for Medical Research

Career Start Year 2004

Number of shared co-authors 2

Cherie T Ng

The Scripps Research Institute

Career Start Year 2004

Number of shared co-authors 1

Kara L Cummings

University of Virginia School of Medicine

Career Start Year 2003

Number of shared co-authors 0

Michael Denton

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Career Start Year 2001

Number of shared co-authors 1

Thomas E Morrison

University of Colorado Anschutz Medical Campus

Career Start Year 2001

Number of shared co-authors 2

Luis Martinez-Sobrido

Texas Biomedical Research Institute

Career Start Year 2001

Number of shared co-authors 2

Jean K Lim

Icahn School of Medicine at Mount Sinai

Career Start Year 1998

Number of shared co-authors 1

Sonja M Best

National Institute of Allergy and Infectious Diseases, National Institutes of Health

Career Start Year 1998

Number of shared co-authors 3

Vladimir Vigdorovich

Center for Global Infectious Disease Research, Seattle Children's Hospital

Career Start Year 1997

Number of shared co-authors 0

Robert H Carnahan

Vanderbilt University Medical Center

Career Start Year 1997

Number of shared co-authors 2

Shelly J Robertson

National Institute of Allergy and Infectious Diseases

Career Start Year 1995

Number of shared co-authors 3

Benhur Lee

Icahn School of Medicine at Mount Sinai

Career Start Year 1995

Number of shared co-authors 2

Daniel N Streblow

Vaccine and Gene Therapy Institute, Oregon Health and Science University

Career Start Year 1994

Number of shared co-authors 1

Keith R Jerome

Fred Hutchinson Cancer Center

Career Start Year 1991

Number of shared co-authors 2

Mark T Heise

University of North Carolina at Chapel Hill.

Career Start Year 1990

Number of shared co-authors 2

Akiko Iwasaki

Yale University

Career Start Year 1990

Number of shared co-authors 2

Bali Pulendran

Institute for Immunity, Stanford University School of Medicine, Stanford University

Career Start Year 1990

Number of shared co-authors 2

Liise-Anne Pirofski

Albert Einstein College of Medicine, Montefiore Medical Center

Career Start Year 1990

Number of shared co-authors 0

Michael N Starnbach

Harvard Medical School

Career Start Year 1988

Number of shared co-authors 4

Olivier Schwartz

Institut Pasteur, Universite Paris Cite, CNRS UMR9

Career Start Year 1987

Number of shared co-authors 3

Leslie Lobel

Ben-Gurion University of the Negev

Career Start Year 1984

Number of shared co-authors 0

Rafick-Pierre Sekaly

Pathology Advanced Translational Research Unit, Emory University School of Medicine

Career Start Year 1981

Number of shared co-authors 3

Judy Lieberman

Boston Children's Hospital

Career Start Year 1978

Number of shared co-authors 2

Merril Gersten

University of California

Career Start Year 1976

Number of shared co-authors 0

Christopher B Wilson

Drukier Institute for Children's Health

Career Start Year 1976

Number of shared co-authors 1

Robert F Garry

Tulane University School of Medicine

Career Start Year 1974

Number of shared co-authors 2

Alan C Whitmore

University of North Carolina at Chapel Hill

Career Start Year 1973

Number of shared co-authors 1

Ronald J Messer

National Institute of Allergy and Infectious Diseases, National Institutes of Health

Career Start Year 1972

Number of shared co-authors 2

row(s) 1 - 30 of 30

Judith E Allen

Lydia Becker Institute for Immunology & Infection, University of Manchester

Co-authored papers 2

Hector C Aguilar

Co-authored papers 2

Robert Nichols

University of California berkeley

Co-authored papers 1

Michael S Diamond

Washington University School of Medicine

Co-authored papers 1

Sarah Stanley

University of California berkeley

Co-authored papers 1

Michael Rape

Howard Hughes Medical Institute, University of California at Berkeley

Co-authored papers 1

Nevan J Krogan (CM4AI)

University of California San Francisco

Co-authored papers 1

Sven Enterlein

Co-authored papers 1

Lucy M Li

Co-authored papers 1

Ivan Mwebaza

Case Western Reserve University School of Medicine

Co-authored papers 1

Stephen L Isaacs

Robert Wood Johnson Foundation in Princeton

Co-authored papers 1

Katie A Lien

Pritzker School of Medicine, University of Chicago

Co-authored papers 1

Manu Vanaerschot

Columbia University Irving Medical Center

Co-authored papers 1

Michael R Emmert-Buck

The Francis Crick Institute

Co-authored papers 1

Eric Lee

School of Public Health, University of California berkeley

Co-authored papers 1

Nadine Czudnochowski

University of California san francisco

Co-authored papers 1

Matt Knight

University of California berkeley

Co-authored papers 1

Isabelle Charles

Co-authored papers 1

Oren S Rosenberg

University of California san francisco

Co-authored papers 1

Arthur Reingold

University of California berkeley

Co-authored papers 1

David P Kateete

College of Health Sciences, Makerere University

Co-authored papers 1

Joanna Vinden

University of California San Francisco

Co-authored papers 1

Jacqueline M Fabius

Quantitative Biosciences Institute (QBI), University of California san francisco

Co-authored papers 1

Stephen J Popper

Sustainable Sciences Institute

Co-authored papers 1

Jackson Gardner

University of California san francisco

Co-authored papers 1

Moses L Joloba

Makerere University.

Co-authored papers 1

Stephen J Elledge

Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School

Co-authored papers 1

Zilose Lyons

California China Climate Institute, University of California berkeley

Co-authored papers 1

Celine Perier

Vall d'Hebron Research Institute (VHIR)

Co-authored papers 1

Samuel Schildhauer

School of Public Health, University of California berkeley

Co-authored papers 1

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators